Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Increasing PrEP With Trans Women in the Deep South

T'Cher, Take Charge: Increasing PrEP Awareness, Uptake and Adherence Through Health Care Empowerment and Addressing Social Determinants of Health Among Racially Diverse Trans Women in the Deep South

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this to address barriers and facilitators to PrEP uptake, and encourage adherence among trans women via a single arm stepped wedge clinical trial. The main question is to compare PrEP uptake and adherence outcomes among trans women in the T'Cher intervention to the delayed study arm.

Who May Be Eligible (Plain English)

Who May Qualify: - Provision of signed and dated willing to sign a consent form form - Declaration of willingness to comply with all study procedures and availability during the study - Age 18 years old or older - Male sex designated at birth - Identify as trans woman, woman or another gender identity not associated with being a man - Desire to use or re-start PrEP - HIV uninfected - Speaks English or Spanish - Live in the New Orleans metropolitan statistical area (which includes 8 parishes) Who Should NOT Join This Trial: - Confirmed HIV infection by rapid algorithm testing and/or laboratory testing (described above) - Prior or current participation in the active arm of an HIV vaccine trial with evidence of vaccine-induced seropositivity - Concurrent or planned enrollment in a research study that provides PrEP - Unwilling to attend quarterly follow-up visits, which will include survey participation - Has any other condition which, based on the opinion of the investigator, would preclude provision of willing to sign a consent form; make participation in the project unsafe; complicate interpretation of outcome data; or otherwise interfere with achieving the project objectives Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Provision of signed and dated informed consent form * Declaration of willingness to comply with all study procedures and availability during the study * Age 18 years old or older * Male sex designated at birth * Identify as trans woman, woman or another gender identity not associated with being a man * Desire to use or re-start PrEP * HIV uninfected * Speaks English or Spanish * Live in the New Orleans metropolitan statistical area (which includes 8 parishes) Exclusion Criteria: * Confirmed HIV infection by rapid algorithm testing and/or laboratory testing (described above) * Prior or current participation in the active arm of an HIV vaccine trial with evidence of vaccine-induced seropositivity * Concurrent or planned enrollment in a research study that provides PrEP * Unwilling to attend quarterly follow-up visits, which will include survey participation * Has any other condition which, based on the opinion of the investigator, would preclude provision of informed consent; make participation in the project unsafe; complicate interpretation of outcome data; or otherwise interfere with achieving the project objectives

Treatments Being Tested

BEHAVIORAL

Peer PrEP Navigation

Ecological momentary assessments to identify and address stressors related to social determinants of health (e.g., housing, substance use, mental health), and motivational interviewing to support participants' health care empowerment and progression along the PrEP continuum.

Locations (1)

NO/AIDS Task Force d.b.a. CrescentCare
New Orleans, Louisiana, United States